Delivery Order SPE2DB24D1205-SPE2DB25FCSXQ

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $26,724.31 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 420 mg vials of the drug ONTRUZANT. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, in support of military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,562.50 firm fixed-price delivery order is for ONTRUZANT 150 MG VIALS, a medical product, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $17,781.12 fixed-price contract is for the supply of ONTRUZANT 420 MG VIALS, a specialty medication. The contract has an ultimate completion date of October 30, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $10,566.04 Firm Fixed Price Delivery Order is for the provision of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $45,833.56, is for the supply of ONTRUZANT 150 MG VIALS, a specialty pharmaceutical product. The contract has a ceiling value of $45,833.56 and an ultimate completion date of September 10, 2024. It is a firm-fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen,...
This federal contract award is for the delivery of ONTRUZANT 150 MG VIALS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a total ceiling value of $11,437.80. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FAZD9, is for the delivery of ONTRUZANT 150 MG VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024, with a ceiling value of $8,080.33. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONTRUZANT 420 MG VIALS. The contract has a potential value of $27,236.77 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $34,823.14 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of the pharmaceutical product ONTRUZANT 420 MG VIALS, with a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a firm fixed price delivery order with a ceiling value of $31,676.90. The award is for the delivery of the pharmaceutical product ONTRUZANT 150 MG VIALS to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSXQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ONTRUZANT 420 MG VIALS. The contract has a ceiling value of $8,115.64 and runs through January 9, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/9/25, 9:47 AM